



after carotid angioplasty 
with stenting – latest review
ABSTRACT
The number of endovascular procedures is constantly increasing. As far as the carotid artery is concerned, carotid angio-
plasty with stenting (CAS) is an alternative to surgical treatment (carotid endarterectomy; CEA).
Two major devastating complications can occur after both procedures – cerebral hyperperfusion syndrome (CHS) and 
intracranial haemorrhage (ICH). 
The incidence of CHS and ICH in CAS is fortunately low but overall morbidity and mortality remains high.
This latest review re-evaluates the pathogenesis, clinical features, risk factors and diagnostic procedures as well as mana-
gement of these two complications.
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Stroke is the third leading cause of 
death and the leading cause of adult 
disability in North America, Europe and 
Asia. Intracranial cerebral atherosclero-
sis accounts for approximately 8-10% 
of all ischaemic strokes. Possible cau-
ses include hypoperfusion, thrombosis 
at the site of stenosis, thromboembolic 
events and direct occlusion of small 
penetrating vessels. (1)
As carotid artery atherosclerosis is an 
important cause of ischaemic stroke, 
correcting the stenosis at the level of 
the carotid vessels is the treatment 
of choice. It can be surgical (carotid 
endarterectomy; CEA) or endovascu-
lar (carotid angioplasty with stenting; 
CAS). (1,2)
The latter has several benefits such as 
shorter hospitalisation, avoidance of 
open neck surgery as well as the ability 
to treat a technically difficult stenosis. 
Whether carotid stenting is superior to 
the classical surgical approach remains 
unclear. Studies have shown that the 
risk of the composite primary outco-
me of stroke, myocardial infarction or 
death, did not differ significantly, howe-
ver there was a higher risk of stroke 
with the endovascular approach and a 
higher risk of myocardial infarction after 
endarterectomy. (1,3)
Late outcomes with CAS are compara-
ble to those of CEA. (2)
Complications of both procedures 
include cerebral embolism, arterial dis-
section, focal hyperperfusion as well 
as cerebral hyperperfusion syndrome 
(CHS) and intracranial haemorrhage 
(ICH). (1,3,4)
CHS was primarily described as a com-
bination of increased blood pressure 
together with clinical signs – ipsilate-
ral migraine - like headache, seizure 
and transient focal neurological deficits 
in the absence of cerebral ischaemia 
after successful carotid endarterecto-
my. (5,6) A similar phenomenon is des-
cribed in the analogue endovascular 
procedure. (6,7)
Another complication of the procedure 
is also well known – ICH. This may be 
a consequence of CHS (6,8) or a com-
pletely different entity as some authors 
propose. (9)
Pathophysiology of cerebral 
hyperperfusion syndrome
The exact mechanism is still unknown 
but seems to be multifactorial in origin. 
(4,6)
However, there are two main mecha-
nisms which contribute to the develo-
pment of CHS – impaired cerebral auto-
regulation as well as postoperatively 
elevated systemic blood pressure. 
The main mechanism in normal cere-
bral autoregulation is cerebrovascular 
reactivity defined as the ability of the 
arterioles to constrict or to dilate in res-
ponse to specific stimuli such as alte-
ration of blood flow or change of partial 
pressure of carbon dioxide. 
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Figure 1. Patient with hyperacute intracranial haemorrhage (ICH) (an hour after carotid angioplasty with stenting 
(CAS)).  
 The right internal cerebral artery (ACI) stenosis was symptomatic - the patient suffered right medium cere-
bral artery (ACM) territory stroke more than a year before the CAS. Risk factors included diabetes mellitus 
and high degree of stenosis. A Tight stenosis of the right ACI with very slow flow to right cerebral hemisp-
here is seen on digital subtraction angiography (DSA). B Magnification view shows near occlusion of the 
ACI caused by calcified plaque. C Stenosis was resolved with two self-expandable stents. D Significantly 
improved flow to the right cerebral hemisphere is seen at the end of the procedure when the patient was 
without clinical signs of hyperperfusion. F Less than an hour after the CAS (refractory hypertension as risk 
factor). E Dramatic neurological deterioration of the patient was caused by a massive ICH  that resulted in a 
fatal outcome. 
Figure 1A. Figure 1B. Figure 1C. 
Patients, who suffer from carotid ste-
nosis, have maximally vasodilatated 
cerebral arterioles in order to maintain 
adequate blood supply to brain tissue. 
The severity of autoregulation impair-
ment depends on several factors such 
Figure 1D. Figure 1E. Figure 1F.
as the duration and the intensity of cere-
bral hypoperfusion. The latter depen-
ds on the grade of ipsilateral carotid 
stenosis, the presence of contralateral 
carotid occlusion as well as the colla-
teral flow. (6)
The loss of ability to dilate in order to 
maintain adequate perfusion is the 
main problem in the pathogenesis of 
CHS. After revascularization, cerebral 
arterioles fail to constrict as a normal 
response to elevated blood pressure. 
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The latter reaches the capillary bed 
and causes cerebral oedema and/or 
haemorrhage. (3)
The second mechanism, encountered in 
the pathogenesis of CHS, is postopera-
tively elevated systemic blood pressure. 
Hypertension is especially well known 
after CEA and it is due to receptor dener-
vation. It leads to increased cerebral 
blood flow and consequently to hyper-
perfusion of previously hypoperfused 
brain tissue. This leads to cerebral oede-
ma and elevated intracranial pressure 
as well as to increased levels of norepi-
nephrine which additionally contribute to 
elevated blood pressure.
Other possible causes include elevated 
cranial levels of norepinephrine due to 
central nervous system sympathomi-
metic mechanism, perioperative stre-
ss and usage of specific anaesthetics 
during the procedure.
The incidence of CHS and 
ICH after CAS 
Hyperperfusion occurs among 10-13% 
of patients. (4,6,10) However, the inci-
Figure 2. Patient with chronic left sided internal cerebral artery (ACI) occlusion and asymptomatic high grade right 
sided ACI stenosis treated with carotid angioplasty with stenting (CAS) in whom signs of hyperperfusion 
occurred 5 days after the procedure. Computer tomography angiography of the right ACI before (A) and after 
(B) the procedure. The patient was urgently readmitted to the hospital 5 days after the CAS due to a sudden 
early morning migraine - like headache localized frontally (non responsive to non steroid analgesics), nausea 
and vomiting. An hour after the first symptoms hemiparesis with bursts of epileptic seizures predominantly 
in the left arm occurred. The only risk factor was poorly controlled long standing hypertension. White matter 
oedema in confined region of the right fronto-parietal region was noticed on computer tomography (CT) (C) 
and magnetic resonance imaging (MRI) (D). E Hyperperfusion in the same confined region was confirmed 
with MR perfusion imaging, as shown on cerebral blood flow map. After admission to the intensive care 
unit for epileptic status, the patient underwent a full neurological recovery. F Follow-up CT one month later 
revealed complete reversibility of changes in brain tissue.
Figure 2A. Figure 2B. Figure 2C. 
Figure 2D. Figure 2E. Figure 2F. 
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dence of clinical manifestations such 
as CHS and ICH is estimated on the 
basis of retrospective reviews and is 
still uncertain – the incidence of CHS 
and ICH after CAS was from 1. 1% and 
as high as 5% (3,6,11)  and from 0. 2% 
to 3.8%. (3,6,9,12)
A comparison of incidence of CHS 
and ICH between CAS and CEA is not 
known to be comparable since antico-
agulants and potent antiplatelet drugs 
are used before and during CAS. (11) 
Recent studies however implicate 
that recipients of CAS are more likely 
to experience ICH. Patients who are 
younger than 70 years of age and are 
symptomatic, are especially prone to 
this devastating complication. (13) The 
comparison of simultaneous bilateral 
CAS and unilateral CAS has not shown 
a statistical difference in CHS and ICH 
incidence. (14) CAS in patients with 
symptomatic carotid near occlusion is 
also not associated with a higher risk for 
CHS/ICH. (15)
Clinical presentation
Symptoms of CHS and ICH can occur 
immediately after the procedure or up 
to several weeks later. Peak onset of 
CHS after CAS is within 12 hours of 
surgery; although it can develop later 
on. (6,9)
Symptoms of CHS are the consequen-
ces of brain oedema and include pulsa-
tile migraine like headache (moderate 
to severe) ipsilateral to revascularised 
artery (typically localised frontotempo-
ral or retro orbital), altered consciou-
sness and confusion as well as ipsila-
teral focal seizures or focal neurological 
deficit without radiographic evidence 
of infarction. (6,9,11) The majority of 
patients experience headache only or a 
minor and transient neurological deficit. 
(3) Manifestations include hemiparesis, 
hemiplegia, hemianopsia, obtundation 
as well as aphasia and epileptic distur-
bances. Some authors also described 
cognitive impairment and psychotic 
disorders. (6)
ICH is usually associated with CHS and 
early manifestations include the symp-
toms of raised intracranial pressure 
such as alterations in sensorium and 
vomiting. The outcome is associated 
with high morbidity and mortality (figure 
1). (6,11)
A special entity, hyperacute ICH, is des-
cribed after CAS. It usually occurs wit-
hin hours (a delay from 8 minutes to 8 
hours after the procedure) and without 
prodromata; it is very unpredictable 
with high mortality. Bleeding is typically 
localised in the basal ganglia and the 
majority of patients present with high 
– grade stenosis before the procedure 
as well as microvascular changes of the 
vessel. (6,9) 
Risk factors
Risk factors for development of CHS/
ICH can be classified into three groups 
and include preoperative (hypertensi-
ve microangiopathy due to long stan-
ding hypertension, diabetes mellitus, 
advanced age, recent procedure on 
contralateral vessel (< 3 months), high 
degree of stenosis with poor collateral 
flow, severe contralateral carotid occ-
lusion, recent stroke and/or ischaemia, 
incomplete circle of Willis, attenuated 
cerebrovascular reactivity after aceta-
zolamide), perioperative (intraoperative 
distal carotid pressure below 40 mmHg, 
high doses of volatile anaesthetics, 
intraoperative cerebral infarction/isc-
haemia) and postoperative (refractory 
postoperative cerebral hyperperfusion, 
postoperative hypertension, admini-
stration of anticoagulants/antiplatelet 
agents). (3,6,15,16)
A recent prospective study perfor-
med on a large cohort of CEA cases 
(841 patients) identified a brief inter-
val between ischaemic symptoms and 
endarterectomy as the clearest risk fac-
tor for CHS. (17) 
Diagnostic methods in 
patients at risk
In order to identify patients at risk seve-
ral methods have been implicated such 
as the usage of transcranial Doppler 
(TCD), computer tomography (CT), 
magnetic resonance imaging (MRI) 
and single-photon emission computed 
tomography (SPECT). (6,16,18) It has 
been proved recently that preoperative 
MRI detection of cerebral microbleeds 
(latent vascular damage) and preope-
rative 123I-iomazenil SPECT imaging 
predicts cerebral hyperperfusion. (19)
Perioperative monitoring includes the 
usage of electroencephalography, 
ocular pneumopletismography, tran-
scranial colour-coded real-time ultra-
sonography with echo contrast agents, 
cerebral circulation time, (3) near infra-
red spectroscopy (NIRS) and intraope-
rative internal carotid artery pressure 
measurement. (3,6,10,20,21) 
It has recently been observed that intra-
operative TCD may not precisely pre-
dict the onset of CHS.  The influence 
of anaesthetic agents on TCD measu-
rements was proposed as a possible 
cause of inaccuracy. (21) Near infrared 
spectroscopy has been reported to be 
a promising noninvasive intraoperative 
method. However, additional studies 
are needed to clearly define regional 
oxygen saturation (rSO2) cut off values 
in NIRS measurements. (20)
Additional methods can be used in the 
postoperative period. Some authors 
propose postoperative CT perfusion 
imaging to detect CHS. (22,23) Posto-
perative MRI and magnetic resonance 
perfusion imaging can also be used as 
shown in our case (figure 2). Novel MRI 
methods include diffusion tensor ima-
ging (DTI) for identifying white matter 
damage caused by CHS. (24)
Management of 
hyperperfusion syndrome
A critical point is identification of pati-
ents with high risk and prevention of 
development of the syndrome. (6) 
Intraprocedural modifications include 
the cautious use of anticoagulation the-
rapy as well as employment of embo-
li-prevention devices and limiting the 
duration of balloon inflation. The latter 
two minimize the risk of intraoperative 
brain ischaemia, which potentiates the 
risk of CHS and ICH.
The role of anticoagulants and/or anti-
platelet agents raises a dramatic safety 
concern in the pathogenesis of ICH. 
Excessive anticoagulation during the 
procedure should be avoided as well 
as the usage of anticoagulants posto-
peratively. (11)
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The anaesthetist plays a key role in the 
endovascular management of patients 
with cerebrovascular atherosclerosis. 
Optimization of comorbidities, meticu-
lous control of systemic physiologic 
variables and aggressive management 
of complications contribute to enhan-
ced patient outcome. (25)
Patients should be admitted to the high 
dependency or intensive care unit after 
the procedure. (3)
Intensive blood pressure monitoring is 
essential; some authors also propose 
the usage of TCD postoperatively. (26) 
Postoperative blood pressure should 
be maintained at normal or slightly 
subnormal levels.  It has been sug-
gested that blood pressures in the 
normal range may be deleterious in 
high risk patients. Antihypertensive 
therapy should be started as soon as 
possible in cases of elevated blood 
pressure. (6,11)
The choice of antihypertensive agent 
remains unclear, however rapid lowe-
ring of blood pressure leads to hypo-
perfusion of end-organ as well as ischa-
emia. The usage of agents with a short 
onset is highly recommended. (27)
Cerebral vasodilator agents such as 
calcium channel blockers or nitrate 
should be avoided. (6,27)
The usage of beta blockers is also limi-
ted due to potential bradycardia after 
revascularization. (6)
Prophylactic anticonvulsant therapy is 
not recommended. However, in cases 
of convulsions, adequate therapy is 
indicated. (6)
Cerebral oedema, which can develop 
after the procedure, should be aggre-
ssively treated with adequate sedati-
on, administration of mannitol and/or 
hyperventilation. Corticosteroids and 
barbiturates have also been used in 
this field.
Due to early discharge after the proce-
dure patients and general practitioners 
should be aware of the complications.
Monitoring of blood pressure and tre-
atment of hypertension is therefore 
strongly recommended for at least two 
weeks after the procedure. 
Patients should return to hospital in 
case of severe headache and/or if 
systolic blood pressure exceeds 160 
mmHg. (6,11,27,28)
Conclusions
The number of endovascular procedu-
res in increasing and so are the com-
plications. 
The role of the interventional neurora-
diologist as well as the rest of the team 
is to prevent, identify and to treat the 
complications as soon as possible. 
Therefore we recommend a multidisci-
plinary approach to patients, especially 
the ones with increased risk.
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